This site is intended for health professionals only

Published on 2 July 2007

Share this story:
Twitter
LinkedIn

Sanofi pulls US rimonabant application

teaser

It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn